Panagora Asset Management’s Altimmune ALT Stock Holding History

Panagora Asset Management’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-122	Closed	-$1K	–	1725
2021 Q2	$1K	Hold	122	–	–	﹤0.01%	2672
2021 Q1	$2K	Hold	122	–	–	﹤0.01%	2700
2020 Q4	$1K	Buy	+122	New	+$1.44K	﹤0.01%	2690
2020 Q2	–	Sell	-1,010	Closed	-$3K	–	2559
2020 Q1	$3K	Hold	1,010	–	–	﹤0.01%	2337
2019 Q4	$2K	Buy	+1,010	New	+$1.86K	﹤0.01%	2352
2017 Q3	–	Sell	-10	Closed	-$1K	–	2309
2017 Q2	$1K	Buy	+10	New	+$1.66K	﹤0.01%	2563

Other funds holding ALT

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Panagora Asset Management's ALT Position: Q3 2021 in Review

Panagora Asset Management sold out of Altimmune (ALT) in Q3 2021, closing a stake of 122 shares — an estimated $1K sold.

Panagora Asset Management first reported a position in ALT in Q2 2017 and held it in 6 quarters. The position peaked at $3K in Q1 2020. 118 funds tracked by Wall St. Rank hold ALT as of Q3 2021.

Panagora Asset Management reported no remaining Altimmune position as of Q3 2021 after selling out during the quarter.
Panagora Asset Management sold 122 Altimmune shares in Q3 2021, an estimated $1K.
Panagora Asset Management first reported a position in Altimmune in Q2 2017 and held it in 6 quarters.
Panagora Asset Management's Altimmune position peaked at $3K in Q1 2020.
118 funds tracked by Wall St. Rank held Altimmune as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.